Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Citi
Moodys
US Army
Julphar
Accenture
Daiichi Sankyo
Fuji

Generated: December 13, 2018

DrugPatentWatch Database Preview

Drug Sales Trends for AMPHETAMINE

« Back to Dashboard

Payment Methods and Pharmacy Types for AMPHETAMINE (2016)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $9,261,155
INSIDE ANOTHER STORE $28,583,318
[disabled in preview] $190,509,085
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 59,841
INSIDE ANOTHER STORE 151,522
[disabled in preview] 1,112,400
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $12,403,806
MEDICARE $20,720,044
[disabled in preview] $195,229,708
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for AMPHETAMINE
Drug Units Sold Trends for AMPHETAMINE

Annual Sales Revenues and Units Sold for AMPHETAMINE

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
AMPHETAMINE ➤ Try a Free Trial ➤ Try a Free Trial 2016
AMPHETAMINE ➤ Try a Free Trial ➤ Try a Free Trial 2015
AMPHETAMINE ➤ Try a Free Trial ➤ Try a Free Trial 2014
AMPHETAMINE ➤ Try a Free Trial ➤ Try a Free Trial 2013
Drug Name Revenues (USD) Units Year

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Julphar
McKinsey
Express Scripts
AstraZeneca
US Department of Justice
Deloitte
Fuji
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.